Gilead Sciences (GILD) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best pharma stocks to invest in. Cantor Fitzgerald analyst Carter Gould ...

Gilead Sciences, Inc. (NASDAQ:GILD) stock is about to trade ex-dividend in 4 days. The ex-dividend date is one business day ...

Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.

The stock's rise snapped a four-day losing streak.

Gilead Sciences, Inc. (GILD), founded in 1987, has long stood as one of America’s most influential biopharmaceutical powerhouses, a company that built its legacy by tackling humanity’s most complex ...

Arcus ends its Phase 3 STAR-221 trial after a futility review and shifts R&D toward casdatifan, supported by strong early RCC ...

Gilead Sciences (GILD) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the ...

Gilead Sciences Inc.’s experimental twice-yearly shot prevented 100% of HIV cases in women and adolescent girls in Africa, the first successful big trial of what’s hoped to become a powerful new drug ...

We recently published a list of 10 Stocks That Analysts Think Will Go Up. In this article, we are going to take a look at where Gilead Sciences, Inc. (NASDAQ:GILD) stands against other stocks that ...

According to Benzinga Pro, Gilead Sciences Inc's peer group average for short interest as a percentage of float is 6.89%, which means the company has less short interest than most of its peers. Did ...

U.S. sues Gilead over role in developing HIV-prevention drug Govt broke pacts with Gilead when it applied for patents -court (Reuters) - A Washington, D.C. federal court said in a decision made public ...